David Kline to Sodium Channel Blockers
This is a "connection" page, showing publications David Kline has written about Sodium Channel Blockers.
Connection Strength
0.166
-
Lorusso S, Kline D, Bartlett A, Freimer M, Agriesti J, Hawash AA, Rich MM, Kissel JT, David Arnold W. Open-label trial of ranolazine for the treatment of paramyotonia congenita. Muscle Nerve. 2019 02; 59(2):240-243.
Score: 0.166